KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Raw Materials (2016 - 2020)

Historic Raw Materials for Amgen (AMGN) over the last 5 years, with Q1 2020 value amounting to $446.0 million.

  • Amgen's Raw Materials rose 6159.42% to $446.0 million in Q1 2020 from the same period last year, while for Mar 2020 it was $446.0 million, marking a year-over-year increase of 6159.42%. This contributed to the annual value of $358.0 million for FY2019, which is 3929.96% up from last year.
  • Latest data reveals that Amgen reported Raw Materials of $446.0 million as of Q1 2020, which was up 6159.42% from $358.0 million recorded in Q4 2019.
  • In the past 5 years, Amgen's Raw Materials ranged from a high of $446.0 million in Q1 2020 and a low of $216.0 million during Q1 2017
  • Moreover, its 5-year median value for Raw Materials was $288.0 million (2018), whereas its average is $293.2 million.
  • Per our database at Business Quant, Amgen's Raw Materials plummeted by 943.4% in 2018 and then soared by 6159.42% in 2020.
  • Amgen's Raw Materials (Quarter) stood at $225.0 million in 2016, then increased by 3.11% to $232.0 million in 2017, then grew by 10.78% to $257.0 million in 2018, then skyrocketed by 39.3% to $358.0 million in 2019, then rose by 24.58% to $446.0 million in 2020.
  • Its Raw Materials was $446.0 million in Q1 2020, compared to $358.0 million in Q4 2019 and $324.0 million in Q3 2019.